Blog | HemaCare

A New Therapy Against Tuberculosis: NOD-2 Derived Dendritic Cells

Jul 27, 2016 1:00:57 PM / by Dalia Gaddis posted in Bone marrow, infections, Innovation, intracellular pathogens, Lung, Mycobacterium, research, tuberculosis

0 Comments

Scientists find that NOD-2 derived dendritic cells have superior bactericidal activity.

Intracellular bacterial infections, such as tuberculosis, Listeria or E. coli, are serious health threats. All can be deadly if our immune system fails to contain and get rid of the infection promptly. Scientists have just found a way to make dendritic cells better at restricting the growth of intracellular bacteria, particularly tuberculosis.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts